Pharmaceutical

Elsie and GSK link to accelerate oligonucleotide discovery platform

Elsie has signed a research collaboration agreement with GSK to accelerate the development of its oligonucleotide discovery platform.

Jul 11, 2023 - 20:00
Elsie and GSK link to accelerate oligonucleotide discovery platform
Elsie has signed a research collaboration agreement with GSK to accelerate the development of its oligonucleotide discovery platform.
Read the original article

Tags:

Previous Article

BeiGene to acquire DualityBio’s ADC therapy for solid tumours

Next Article

MHRA approves GSK’s RSV vaccine for older adults in the UK

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Roche’s $3 billion Alnylam deal shows drug firms are interested in long-acting heart drugs

STAT+: Roche’s $3 billion Alnylam deal shows drug firms...

Jul 24, 2023

Leading innovators in ssRNA virus peptides for the pharmaceutical industry

Leading innovators in ssRNA virus peptides for the phar...

May 8, 2023

STAT+: Congress targets reducing hospital outpatient payments in new bills

STAT+: Congress targets reducing hospital outpatient pa...

Apr 19, 2023